NO972219L - Immunogenpreparater - Google Patents

Immunogenpreparater

Info

Publication number
NO972219L
NO972219L NO972219A NO972219A NO972219L NO 972219 L NO972219 L NO 972219L NO 972219 A NO972219 A NO 972219A NO 972219 A NO972219 A NO 972219A NO 972219 L NO972219 L NO 972219L
Authority
NO
Norway
Prior art keywords
immunogen
antigens
solvent
preparation according
preparation
Prior art date
Application number
NO972219A
Other languages
English (en)
Norwegian (no)
Other versions
NO972219D0 (no
Inventor
Roger Randal Charles New
Original Assignee
Cortecs Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cortecs Ltd filed Critical Cortecs Ltd
Publication of NO972219D0 publication Critical patent/NO972219D0/no
Publication of NO972219L publication Critical patent/NO972219L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/08—Clostridium, e.g. Clostridium tetani
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NO972219A 1994-11-15 1997-05-14 Immunogenpreparater NO972219L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9422990A GB9422990D0 (en) 1994-11-15 1994-11-15 Immunogenic compositions
PCT/GB1995/002675 WO1996014871A1 (en) 1994-11-15 1995-11-14 Immunogenic compositions

Publications (2)

Publication Number Publication Date
NO972219D0 NO972219D0 (no) 1997-05-14
NO972219L true NO972219L (no) 1997-07-11

Family

ID=10764393

Family Applications (1)

Application Number Title Priority Date Filing Date
NO972219A NO972219L (no) 1994-11-15 1997-05-14 Immunogenpreparater

Country Status (19)

Country Link
EP (1) EP0792165B1 (de)
JP (1) JP4297515B2 (de)
KR (1) KR970706848A (de)
CN (1) CN100346828C (de)
AT (1) ATE249841T1 (de)
AU (1) AU700910B2 (de)
CA (1) CA2205083A1 (de)
DE (1) DE69531793T2 (de)
DK (1) DK0792165T3 (de)
ES (1) ES2210318T3 (de)
FI (1) FI972054A7 (de)
GB (1) GB9422990D0 (de)
IL (1) IL116010A0 (de)
MX (1) MX9703480A (de)
NO (1) NO972219L (de)
NZ (1) NZ295238A (de)
PT (1) PT792165E (de)
WO (1) WO1996014871A1 (de)
ZA (1) ZA959729B (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9323588D0 (en) 1993-11-16 1994-01-05 Cortecs Ltd Hydrophobic preparation
US6165773A (en) * 1995-10-25 2000-12-26 Provalis Uk Limited Methods of preserving viruses
GB9613858D0 (en) 1996-07-02 1996-09-04 Cortecs Ltd Hydrophobic preparations
AU736038C (en) * 1997-07-10 2006-08-10 Intervet Australia Pty Limited Non-aqueous vaccines
WO1999002182A2 (en) * 1997-07-10 1999-01-21 Biotech Australia Pty. Limited Non-aqueous vaccines
CA2320041A1 (en) * 1998-02-12 1999-08-19 American Cyanamid Company Vaccines comprising interleukin-12 and herpes simplex viral antigen
AU2596699A (en) * 1998-02-12 1999-08-30 American Cyanamid Company Vaccines comprising interleukin-12 and respiratory syncytial viral antigens
CN1200730C (zh) * 1998-02-12 2005-05-11 惠氏控股有限公司 用白细胞介素－12配制的肺炎球菌和脑膜炎球菌疫苗
US6630161B1 (en) * 1998-05-07 2003-10-07 Ribi Immunochem Research, Inc. Adjuvant composition and methods for its use
WO2000003724A1 (en) * 1998-07-16 2000-01-27 Hayashi, Akira Preparations for immunotherapy for cancer having bacterial somatic constituent as the active ingredient
JP5731198B2 (ja) 2007-09-27 2015-06-10 イムノバクシーン・テクノロジーズ・インコーポレイテッドＩｍｍｕｎｏｖａｃｃｉｎｅ Ｔｅｃｈｎｏｌｏｇｉｅｓ Ｉｎｃ． インビボでのポリヌクレオチドの送達のための連続疎水相を含む担体におけるリポソームの使用
JP5591705B2 (ja) * 2007-10-03 2014-09-17 イムノバクシーン・テクノロジーズ・インコーポレイテッド 抗原、両親媒性化合物及び疎水性担体を含有する組成物、並びにその使用
BRPI0913612B8 (pt) 2008-06-05 2021-05-25 Immunovaccine Technologies Inc composição injetável de vacina, método para obter a composição e uso da composição
CN103517714A (zh) * 2010-12-23 2014-01-15 英珀特疗法有限公司 用于刚地弓形虫感染和弓形体病的诊断和治疗的方法和蛋白抗原组合物
GB201107629D0 (en) 2011-05-06 2011-06-22 Proxima Concepts Ltd Hydrophobic preparations
CN102277373B (zh) * 2011-08-15 2014-07-02 南京大学 一种减毒沙门氏菌分泌表达的日本血吸虫疫苗表达载体及其应用
US10105435B2 (en) 2011-10-06 2018-10-23 Immunovaccine Technologies Inc. Liposome compositions comprising an adjuvant that activates or increases the activity of TLR2 and uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4578391A (en) * 1982-01-20 1986-03-25 Yamanouchi Pharmaceutical Co., Ltd. Oily compositions of antitumor drugs
IE904098A1 (en) * 1989-11-13 1991-05-22 Nova Pharm Corp Lipospheres for controlled delivery of substances
DE69232940T2 (de) * 1991-06-26 2003-08-28 Yamanouchi Europe B.V., Leiderdorp Vesiculae in nichtpolaren Medien
AU7384994A (en) * 1993-08-06 1995-02-28 Opperbas Holding B.V. A method for high loading of vesicles with biopolymeric substances
GB9323588D0 (en) * 1993-11-16 1994-01-05 Cortecs Ltd Hydrophobic preparation

Also Published As

Publication number Publication date
DK0792165T3 (da) 2004-01-05
JPH10508834A (ja) 1998-09-02
CA2205083A1 (en) 1996-05-23
NO972219D0 (no) 1997-05-14
ZA959729B (en) 1997-05-15
FI972054L (fi) 1997-05-14
ATE249841T1 (de) 2003-10-15
GB9422990D0 (en) 1995-01-04
EP0792165B1 (de) 2003-09-17
DE69531793T2 (de) 2004-07-15
CN1163575A (zh) 1997-10-29
EP0792165A1 (de) 1997-09-03
PT792165E (pt) 2004-02-27
FI972054A0 (fi) 1997-05-14
CN100346828C (zh) 2007-11-07
AU700910B2 (en) 1999-01-14
ES2210318T3 (es) 2004-07-01
NZ295238A (en) 1999-01-28
FI972054A7 (fi) 1997-05-14
DE69531793D1 (de) 2003-10-23
AU3853495A (en) 1996-06-06
IL116010A0 (en) 1996-01-31
JP4297515B2 (ja) 2009-07-15
KR970706848A (ko) 1997-12-01
MX9703480A (es) 1997-08-30
WO1996014871A1 (en) 1996-05-23

Similar Documents

Publication Publication Date Title
NO972219L (no) Immunogenpreparater
US5716637A (en) Solid fat nanoemulsions as vaccine delivery vehicles
US5961970A (en) Submicron emulsions as vaccine adjuvants
Alving Design and selection of vaccine adjuvants: animal models and human trials
WO1995011700A1 (en) Submicron emulsions as vaccine adjuvants
MXPA97003480A (en) Immunogeni compositions
US9603799B2 (en) Liposomal vaccine adjuvants and methods of making and using same
WO2009043165A1 (en) Compositions comprising an antigen, an amphipathic compound and a hydrophobic carrier, and uses thereof
US20130195932A1 (en) Archaeal polar lipid aggregates for administration to animals
Gregoriadis Liposomes as immunological adjuvants for peptide and protein antigens
AU744308B2 (en) Antigen vectors in the form of multilamellar vesicles
US20100209452A1 (en) Compositions comprising an antigen, an amphipathic compound and a hydrophobic carrier, and uses thereof
US20160136250A1 (en) Hydrophobic Preparations
WO2001019335A2 (fr) Compositions destinees a une administration par voie muqueuse
Muderhwa et al. Emulsification of liposomes with incomplete Freund's adjuvant: Stability of the liposomes and the emulsion
FR2850872A1 (fr) Composition vaccinale destinee a induire une reponse immunitaire contre le virus responsable du sida
Wilkhu et al. Designing nonionic surfactant vesicles for the delivery of antigens for systemic and alternative delivery routes
RU97110170A (ru) Иммуногенные композиции
WO2012152707A1 (en) Microemulsions

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application